Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists

被引:6
作者
Leslie, Colin P. [1 ]
Bentley, Jonathan [1 ]
Biagetti, Matteo [1 ]
Contini, Stefania [1 ]
Di Fabio, Romano [1 ]
Donati, Daniele [1 ]
Genski, Thorsten [1 ]
Guery, Sebastien [1 ]
Mazzali, Angelica [1 ]
Merlo, Giancarlo [1 ]
Pizzi, Domenica A. [1 ]
Sacco, Fabiola [1 ]
Seri, Catia [1 ]
Tessari, Michela [1 ]
Zonzini, Laura [1 ]
Caberlotto, Laura [1 ]
机构
[1] GlaxoSmithKline SpA, Med Res Ctr, Neurosci Ctr Excellence Drug Discovery, I-37135 Verona, Italy
关键词
NPY Y5; NEUROPEPTIDE-Y; RECEPTOR ANTAGONISTS; PEPTIDE-YY; DERIVATIVES; LIGANDS;
D O I
10.1016/j.bmcl.2010.08.041
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of trans-8-aminomethyl-1-oxa-3-azaspiro[4.5] decan-2-one derivatives was identified with potent NPY Y5 antagonist activity. Optimization of the original lead furnished compounds 23p and 23u, which combine sub-nanomolar Y5 activity with metabolic stability, oral bioavailability, brain penetration and strong preclinical profile for development. Both compounds significantly inhibited the food intake induced by a Y5 selective agonist with minimal effective doses of 3 mg/kg po. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6103 / 6107
页数:5
相关论文
共 24 条
[1]   Y-receptor subtypes - How many more? [J].
Blomqvist, AG ;
Herzog, H .
TRENDS IN NEUROSCIENCES, 1997, 20 (07) :294-298
[2]   DIMETHYLOXOSULFONIUM METHYLIDE ((CH3)2SOCH2) AND DIMETHYLSULFONIUM METHYLIDE ((CH3)2SCH2) FORMATION AND APPLICATION TO ORGANIC SYNTHESIS [J].
COREY, EJ ;
CHAYKOVSKY, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1965, 87 (06) :1353-+
[3]   Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults [J].
Erondu, Ngozi ;
Gantz, Ira ;
Musser, Bret ;
Suryawanshi, Shailaja ;
Mallick, Madhuja ;
Addy, Carol ;
Cote, Josee ;
Bray, George ;
Fujioka, Ken ;
Bays, Harold ;
Hollander, Priscilla ;
Sanabria-Bohorquez, Sandra M. ;
Eng, WaiSi ;
Langstrom, Bengt ;
Hargreaves, Richard J. ;
Burns, H. Donald ;
Kanatani, Akio ;
Fukami, Takehiro ;
MacNeil, Douglas J. ;
Gottesdiener, Keith M. ;
Amatruda, John M. ;
Kaufman, Keith D. ;
Heymsfield, Steven B. .
CELL METABOLISM, 2006, 4 (04) :275-282
[4]  
Félétou Michel, 2006, CNS & Neurological Disorders-Drug Targets, V5, P263, DOI 10.2174/187152706777452236
[5]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171
[6]   Neuropeptide Y receptor selective ligands in the treatment of obesity [J].
Kamiji, M. M. ;
Inui, A. .
ENDOCRINE REVIEWS, 2007, 28 (06) :664-684
[7]   Regulation of maternal food intake and mother-pup interactions by the Y5 receptor [J].
Ladyman, Sharon R. ;
Woodside, Barbara .
PHYSIOLOGY & BEHAVIOR, 2009, 97 (01) :91-97
[8]   Discovery of novel orally active ureido NPYY5 receptor antagonists [J].
Li, Guoqing ;
Stamford, Andrew W. ;
Huang, Ying ;
Cheng, Kuo-Chi ;
Cook, John ;
Farley, Constance ;
Gao, Jun ;
Ghibaudi, Lorraine ;
Greenlee, William J. ;
Guzzi, Mario ;
van Heek, Margaret ;
Hwa, Joyce J. ;
Kelly, Joe ;
Mullins, Deborra ;
Parker, Eric M. ;
Wainhaus, Sam ;
Zhang, Xiaoping .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) :1146-1150
[9]   Role of the Y5 neuropeptide Y receptor in feeding and obesity [J].
Marsh, DJ ;
Hollopeter, G ;
Kafer, KE ;
Palmiter, RD .
NATURE MEDICINE, 1998, 4 (06) :718-721
[10]   Effects of a novel Y5 antagonist in obese mice: Combination with food restriction or sibutramine [J].
Mashiko, Satoshi ;
Ishihara, Akane ;
Iwaasa, Hisashi ;
Moriya, Ryuichi ;
Kitazawa, Hidefumi ;
Mitobe, Yuko ;
Ito, Junko ;
Gomori, Akira ;
Matsushita, Hiroko ;
Takahashi, Toshiyuki ;
MacNeil, Douglas J. ;
Van der Ploeg, Lex H. T. ;
Fukami, Takehiro ;
Kanatani, Akio .
OBESITY, 2008, 16 (07) :1510-1515